In addition, several other identified targets, such as RET, FGFR3, NCAM1, TYMP, TNFRSF10B, MMP3, TACSTD2, and NOTCH2, were implicated in various cancers and present potential therapeutic avenues. This evidence concerns the gene FGFR3 and cancer.